Finch Therapeutics Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Finch Therapeutics Group generated cash of -$31,505,000, which is more than the previous year. Cash used in financing activities reached the amount of -$16,155,000 last year. Net change in cash is therefore -$46,333,000.
Cash Flow
| 2019 | -17.32M | -973K | 53.3M |
|---|---|---|---|
| 2020 | -31.32M | -2.63M | 91.47M |
| 2021 | -67.13M | -15.92M | 119.11M |
| 2022 | -74.85M | -2.18M | 14.87M |
| 2023 | -31.50M | 1.32M | -16.15M |
FNCH Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 73.80M | 135.96M | 99.90M | 42.39M | 7.38M |
Operating activities | |||||
Net income | -74.75M | -114.64M | -58.16M | -39.34M | -20.75M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.52M | 5.50M | 2.30M | 790K | 482K |
Stock-based compensation expense | 1.92M | 7.84M | 4.16M | 3.09M | 606K |
| Deferred income tax benefit | 1.92M | 7.84M | 4.16M | 3.09M | 606K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 143K | 350K | 540K | 143K | 1.2M |
Inventories | 0 | 0 | -3.68M | 255K | 43K |
Accounts payable | -956K | -2.25M | 2.26M | 440K | -1.05M |
Cash generated by operating activities | -31.50M | -74.85M | -67.13M | -31.32M | -17.32M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -2.18M | -15.98M | -2.63M | -1.00M |
Acquisitions Net | 0 | 0 | 62K | 0 | 32K |
Cash generated by investing activities | 1.32M | -2.18M | -15.92M | -2.63M | -973K |
Financing activities | |||||
Common Stock Issued | 0 | 289K | 118.57M | 59K | 150K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -245K |
Repayments of term debt | -16.15M | 14.71M | -27K | -47K | 4.72M |
Cash used in financing activities | -16.15M | 14.87M | 119.11M | 91.47M | 53.3M |
Net Change In Cash | -46.33M | -62.16M | 36.05M | 57.51M | 35.00M |
Cash at end of period | 27.47M | 73.80M | 135.96M | 99.90M | 42.39M |
| Data source | Data source | Data source |